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Abstract
Food and nutrition guidelines for the handling and processing of fresh fruit, bread, and vegetables are essential
and fresh produce may require cold preservation procedures to prevent minimal bacterial and fungi
contamination of food. Bacterial lipopolysaccharides (LPS) corrupt lipoprotein and amyloid beta (Aβ)
metabolism in diabetes, Alzheimer’s disease (AD) and various neurological diseases. In the developing world the
increased plasma LPS levels induce non-alcoholic fatty liver diseases and interfere with albumin and Aβ
interactions with spontaneous Aβ oligomer formation in the cerebrospinal fluid and brain that leads to neuron
apoptosis by inactivation of Starling’s equation that is responsible for the maintenance of hydrostatic and oncotic
pressure with relevance to fluid balance. In the developing world increased levels of LPS, mycotoxin and
xenobiotics lead to irreversible neurological diseases by inhibition of Starling’s equation for maintenance of
oncotic/osmotic pressure that lead to neuron senescence or apoptosis. In the developed world nutrigenomic diets
are required that prevent Sirtuin 1 gene repression and maintain neuron survival that links the brain and
peripheral hepatic monomer Aβ metabolism. The maintenance of blood-cerebrospinal fluid capillary transport of
albumin and monomer Aβ is relevant to stabilization of neurons not only in Alzheimer’s disease but also in Type
3 diabetes and various neurological diseases. Healthy diets reverse the inhibition of brain to peripheral Aβ
transport that is sensitive to Starling’s equation for regulation of central nervous system hydrostatic and oncotic
pressure with the prevention of diabetes, various neurological diseases and Alzheimer’s disease.
Keywords: diet, lipopolysaccarides, albumin, Starling equation, amyloid beta, neurologic disease, Alzheimer’s
disease, diabetes
1. Introduction
The gene-environment interaction may indicate a population’s risk to chronic disease progression with effects of
diet that may override genomic expression in populations. In the developing and developed world the United
States of America may be a good example of populations that include Caucasians, African Americans, Hispanics,
Native Americans, Pacific Islanders or Asians for assessment for neurological diseases. Neurological diseases
include Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s disease, autism and neurodevelopmental
disorders, neuromuscular disorders/peripheral neuropathies and neurobehavioural disorders. Neurodegeneration
is referred to as the accelerated aging of neurons leading to alterations in shape, size and stability of neurons in
these neurological diseases.
Interests in premature aging, food and nutrition science may assist in the understanding of diets involved with
brain astrocyte aging essential for neuronal survival (Martins & Creegan, 2014; Rodrí
guez-Arellano et al, 2016).
Neurons and various cells in the body synthesize amyloid beta a monomeric 4 kd peptide that is extremely
susceptible to self-aggregation as toxic oligomer species (Yun et al, 2007) and spontaneous fibril formation and
transport of the monomeric amyloid beta (Aβ) species from the brain across the blood brain barrier to the plasma
compartment is required for rapid metabolism to the liver (Martins, 2015).
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In AD and various other neurological diseases such as a miscible chronic disease that involves Type 3 diabetes
(Martins, 2015) may lead to early aging with neuron senescence and associated with food quality and safety
(Martins, 2015). Interest in the calorie sensitive gene Sirtuin 1 (Sirt 1) (Herskovits & Guarente, 2014; Tang &
Chua, 2008, Guarente, 2007, Hansen & Connolly, 2008) have accelerated with relevance to food and nutrition
with its downregulation associated with neuron senescence, circadian rhythm abnormalities with relevance to
defective Aβ metabolism in various neurological diseases. Sirt 1 is a NAD(+) dependent class III histone
deacetylase protein that targets transcription factors to adapt gene expression to metabolic activity, insulin
resistance and inflammation in chronic diseases. Nutritional regulation (calorie restriction) of Sirt1 is involved in
neuron proliferation with effects on cellular cholesterol closely linked to Aβ clearance in AD (Martins, 2015).
Microbiological spoilage of food in the developing world has become important with unsafe food that contains
harmful bacteria (WHO/Food safety, 2015). Microbiological contamination of food can occur at the place of
production or at the market place and home. Unsafe gram negative bacteria may reside in unpasteurized milk,
undercooked meat and fresh fruits and vegetables that are poorly distributed or stored. Delayed transport of food
products may allow temperature related modification of food production, storage and distribution with high
bacterial/fungal contamination (Hymery, et al, 2014; Makun, 2013; Leff & Fierer, 2013; Howel, 1912). Many
publications in the developed world indicate that hypercholesterolemia is connected obesity, Type II diabetes and
neurological diseases and numerous studies have linked defective high density lipoprotein (HDL) metabolism to
cardiovascular disease and neurodegeneration (Hottman et al. 2014). Food quality and food science has now
become important to determine the effects of ingested food that contain microbiological contamination on
defective HDL cholesterol metabolism and the induction of non alcoholic liver disease (NAFLD) that has
reached epidemic levels in the world (Younossi et al. 2016).
Lipopolysaccarides (LPS) are endotoxins and essential components of the outer membrane of all Gram-negative
bacteria. LPS from bacteria share common features in their basic architecture and consists of three covalently
linked segments, a surface carbohydrate polymer (O-specific chain), a core oligosaccharide featuring an outer
and inner region and an acylated glycolipid (termed Lipid A). The O-specific chain shows the most diversity and
Lipid A anchors the LPS molecule in the Gram-negative outer membrane and is most conserved in bacteria
species. LPS can rapidly insert into cell membranes with a preference for insertion and partition into
cholesterol/sphingomyelin domains in cell membranes (Martins, 2015; Ciesielski et al, 2012). LPS has been
associated with repression of the anti-aging gene Sirt 1 with relevance to metabolic diseases, NAFLD, diabetes
and Alzheimer’s disease (Martins, 2015; Martins, 2015; Martins, 2016; Martins, 2016; Martins, 2016).
Dietary fat increase plasma endotoxins such as LPS into the blood plasma (Feingold et al, 1992;Miele, et al, 2013;
Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014) that bind to LPS binding proteins, lipoproteins and cell
receptors (Fenton & Golenbock, 1998). Lipoproteins such as chylomicron that are produced after taking a meal
high in fats contain the LPS binding protein (LBP) that bind LPS and are essential for interactions of LPS to apo
B containing cholesterol-rich lipoproteins (chylomicron remnants, very low density lipoproteins, high density
lipoproteins). Interest in LPS in relation to dyslipidemia has escalated with relevance to the neutralization of apo
E by binding of LPS (amphipathic α-helix organization) and the toxic effects of LPS are neutralized in the body
by rapid transport to the liver for metabolism (Martins, 2015). Increased plasma LPS elicit hepatic release of
cytokines and acute phase proteins (APP) and lipoproteins such as HDL that contain apo E and apolipoprotein AI
(apo AI) may classically be involved in the modulation of the inflammatory response that involve the liver and
immune cells (Martins, 2015).
Interactions between HDL and lipoproteins (chylomicrons, very low density lipoproteins, low density
lipoproteins) with relevance to cholesterol transport that involve lipid transfer proteins such as cholesterol ester
transport proteins and phospholipid transport proteins has become important with relevance to LPS and its
interactions with phospholipid and cholesterol transport to lipoproteins and cell membranes (Martins, 2015;
Martins, 2016). Interactions between LPS and apo AI have also been reported with effect on LPS on
inflammatory responses and diminished by apo AI function with detrimental effects on HDL and reverse
cholesterol transport (Henning et al, 2006;Wang et al, 2008; Gupta et al, 2005). Therefore LPS has detrimental
effects on HDL metabolism and reverse cholesterol transport that involve neutralization of apo E and apo AI
with the induction of dyslipidemia and NAFLD.
2. Amyloid Beta Metabolism Is Defective in Alzheimer’s Disease and Neurological Diseases and Associated
with Chronic Diseases
The role of cholesterol in modulating the expression of amyloid precursor protein (APP) and the levels of cell Aβ
have been reported. The cholesterol receptors low density receptor related protein 1 (LRP-1) and low density
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lipoprotein receptor (LDL r) act on the blood brain barrier (BBB) and regulate the transport of Aβ from the brain
to the periphery (Martins, 2015). In chronic diseases such as obesity and diabetes excessive food intake may
increase plasma LPS levels with interference with Sirt 1’s circadian regulation (Martins, 2016) of Aβ metabolism
by corruption of peripheral plasma Aβ metabolism in both Alzheimer’s disease and various neurological diseases
(Erickson et al, 2012). In various neurological diseases the transport of Aβ is corrupted with several reports of
BBB disorders associated with neurodegenerative diseases (Rosenberg, 2012; Kanwar, et al, 2012).
Sirt 1 is also responsible for alpha-synuclein metabolism with alpha-synuclein important to interactions with
cholesterol in cell membranes relevant to Aβ metabolism (Martins, 2015). Albumin has been shown to bind Aβ
and LPS with levels of LPS being reported to decrease in plasma albumin levels. The plasma, CSF and the brain
Aβ’s self aggregation properties can be determined by the levels of albumin and vitamin E levels with the
circadian variations of CSF protein (Nilsson, et al, 1992) under the influence of Sirt 1. CSF in neurological and
AD individuals contain apo E with essential involvement in amyloid beta clearance and metabolism (Hesse et al.,
2000; Cruchaga et al., 2012). LPS is involved with the neutralization of apo E and the induction of NAFLD
(Martins, 2015; Harte et al., 2010; Miele et al., 2013) with lower CSF albumin levels and inactivated apo E
associated with defective CSF transport of amyloid beta relevant to accelerated amyloid beta aggregation in the
CSF. The interest in CSF Aβ metabolism in diabetes (Kobessho, et al, 2008; Manschot, et al, 2008) and
neurological diseases has accelerated with neurological disease now linked primarily to dietary LPS plasma
levels, insulin resistance and accelerated Aβ aggregation.
Research in the role of LPS in the peripheral sink Aβ hypothesis (Martins, 2015) has escalated with the improved
understanding of the LPS effects on astrocytes and neurons in the brain and effects on the transport across the
blood brain barrier (BBB). LPS has been associated with impaired Aβ efflux across the BBB with the
downregulation of the (LRP-1) that has previously been shown to be critical to the Aβ efflux from the brain (Lee
et al., 2008). The effects of systemic LPS on disturbed Aβ homeostasis are relevant to Aβ generation (Lee et al.,
2008; Llewellyn et al., 2010). Activation of inflammation in astrocytes by LPS corrupt the important role of
astrocytes in the metabolism of neuronal Aβ (24) with the development of AD. In the brain the CD14 receptor is
referred to as the LPS receptor and involved with Aβ metabolism (Martins & Creegan, 2014). LDL receptor
deficiency was associated with astrocytosis with increased amyloid deposition and implicate LPS and
interactions with the LDLr in astrocyte-neuron Aβ metabolism (Martins, 2015; Martins & Creegan, 2014).
The Starling equation (Starling, 2016) indicates the movement of fluid across membranes by calculation of
hydrostatic and oncotic pressure that involve the blood: CSF barrier and CSF: blood brain barrier (Feingold et al,
1992;Miele, et al, 2013; Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014). In the Starling equation as
shown below the reflection coefficient (sigma) is a correction factor that indicates changes in the oncotic
pressure as a result of protein changes in the CSF compartment. Cappillary membranes do not allow large
molecular weight proteins to pass into the CSF compartment but albumin and monomeric Aβ has access to the
CSF compartment to maintain the oncotic pressure.
The adapted Starling equation () reads as follows:
where:
is the net fluid movement between compartments.
is the net driving force,
o Pc is the capillary hydrostatic pressure
o Pi is the interstitial hydrostatic pressure
o πc is the capillary oncotic pressure
o πi is the interstitial oncotic pressure
o Kf is the filtration coefficient – a proportionality constant
o σ is the reflection coefficient
The reflection coefficient correction factor will change when LPS arrives into the plasma/ CSF compartment by
a reduction in albumin and spontaneous aggregation of Aβ (Figure 1) with complete corruption of the peripheral
clearance Aβ pathway (Martins, 2015) relevant not only to Alzheimer’s disease but also to diabetes and various
neurological diseases. LPS will change membrane fluidity (Martins 2015; Martins, 2016) with effects on the
filtration coefficient of the Starling equation at the blood:CSF barrier and CSF:blood brain barrier with
corruption of the influx and efflux of Aβ (Martins, 2016). LPS effects on brain membrane fluidity (Figure 1)
supersede phospholipid and monomer Aβ membrane interactions with the promotion of non-Brownian Aβ
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dynamics in the plasma, CSF and brain (Martins, 2015; Martins, 2016). Effects of LPS on Aβ transport involve
alpha synuclein with effects on membrane fluidity that involve cholesterol (Martins, 2015) and Aβ oligomers in
the CSF and brain with LPS involved in the transformation of membranes in capillaries that override the
filtration coefficient that determines protein (albumin/Aβ) transport in the CSF and brain (Figure 1).

Figure 1. Unhealthy diets increase LPS levels with effects in the cerebrospinal fluid that promote amyloid beta
aggregation with corruption of membrane fluidity (blood:CSF barrier and CSF:blood brain barrier) and do not
allow the passage of essential proteins such as albumin into the CSF. LPS effects on Starling equation is
associated with increased oncotic pressure and associated with defects in the brain transport of amyloid beta
from the CNS via the cerebrospinal fluid into the plasma for metabolism by the liver.
The effects of bacterial LPS to chronic disease may be linked to developing or third world countries associated
with poor hygiene standards and poor food storage and corruption of Starling Law may lead to irreversible
autonomous disease associated with central nervous system fluid balance dyshomeostasis (Feingold et al,
1992;Miele, et al, 2013; Le Roy et al, 2013; Alisi, et al, 2012; Duseja, et al, 2014). LPS in these developing
countries repress Sirt 1 expression and completely inactivate the brain from the periphery with a defect in Aβ
metabolism. In these developing countries mycotoxin (Martins, 2015) and xenobiotics levels (Martins, 2013)
found in food and water may be elevated and may further induce CSF Aβ aggregation and elevated oncotic
pressure diseases (Martins, 2013). Sirt 1 is a calorie sensitive gene and in the developed world nutrigenomic
diets (Sirt 1 upregulation) may be appropriate to reverse circadian rhythm abnormalities with effects on
improved peripheral amyloid beta metabolism with decreased CSF amyloid aggregation and improvements in
calculations for the Starling equation by CNS albumin and amyloid beta transport with relevance to fluid
transport to the brain (Starling, 2016; Buishas et al, 2014). Dietary intake in the developing and developed world
in various chronic and neurologic diseases need dietary modifications with lifestyle changes to allow reversal of
defective Aβ metabolism and physiological fluid balances that are essential for neuron survival and reversal of
accelerated aging.
3. Food Quality and the Nature of Diet Maintains Post-Prandial Lipid and Amyloid Beta Metabolism
Relevant To Diabetes and Neurological Diseases
The consumption of the very low carbohydrate and low fat diets (Martins, 2015) are required to prevent LPS
absorption and prevent LPS repression of the anti-aging gene Sirt 1 that is now linked to the defective
gene-environment interactions involved in defective liver cholesterol metabolism (post-prandial) associated with
insulin resistance, NAFLD disturbed brain Aβ transport in various neurological diseases. Furthermore, healthy
diets that maintain LPS and protein interactions with proteins such as albumin, lactoferrin and transferrin and
other acute phase proteins/glycoasminoglycans delay LPS induced Aβ toxic oligomer formation connected to
neuron number important to thinking and intelligence (Martins, 2016).
In obesity and diabetes the LPS level in the blood plasma are elevated and related to hyperglycemia and NAFLD
(Harte et al., 2010; Miele et al., 2013). In the developing and developed world dairy products such as French
cheese and yoghurt (Arslan et al. 2011; Coton et al., 2011; Hickey et al., 2015) should be consumed as
recommended by food safety practices. Gram negative bacteria such as E Coli and Pseudomonas aeruginosa
(Arslan et al. 2011) can be involved in the fermentation and food spoilage that release LPS into the intestine.
Diets that are high in fat and cholesterol stimulate LPS absorption (Huang, et al.; 2007 Lee, 2013) with increased
risk for NAFLD (Harte et al., 2010; Miele et al., 2013). Dairy foods such as cheese and yogurt may involve
many variables that include the milk preparation and temperature (storage, light, time). Modern technologies that
involve freezers with safe storage time and lifetime in the food industry do not allow for microbiological
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contamination (gram negative bacteria) in the developed world compared with the developing world.
The potent effects of apple and cheese spoilage produces the mycotxon patulin that can be concentrated in the
brain and liver with the corruption of the apo E mediated clearance of Aβ induced by patulin with relevance to
post-translational modification of proteins (Martins, 2015). Ochratoxin A (OTA) is found in the rind and inner
part of the cheese, coffee and in alcohol (beer, wine) and can lead to increased OTA to the brain with neuron
apoptosis. Alcohol (apple cocktail, beer, wine) promotes the intestinal absorption of LPS and myoctoxin and
alcohol is a Sirt 1 inhibitor with relevance to corruption of the brain and peripheral regulation of Aβ metabolism.
Stress and lifestyle changes may induce an apelinergic dysfunction (Martins, 2015) with individuals in the
developing world more susceptible to CSF Aβ aggregation associated with the absence of the brain to peripheral
links in hepatic Aβ metabolism.
Activators of Sirt 1 (nutrigenomic diets) are required such as leucine, pyruvic acid and magnesium (Martins,
2016) that maintain hepatic and brain Sirt 1 activity to prevent delayed hepatic cholesterol and brain Aβ
metabolism with relevance to Type 3 diabetes and NAFLD (Martins, 2016). Excessive phosphatidylinositol
doses (gm/day) (Martins, 2015) need to be administered to individuals in the developing world to reverse plasma,
CSF and brain Aβ aggregation with phosphatidylinositol doses important to therapeutic effects on membrane
stability and fluid filtration. Central acting CNS drugs to maintain oncotic/osmotic pressure in diabetes and
various neurological diseases need to be consumed with excellent food quality to prevent
LPS/mycotoxin/xenobiotic ill effects (Martins, 2015; Martins, 2016). LPS/mycotoxin contamination can be
associated with the packing, storage, transportation, handling, and processing of fresh produce to the final
destination needs to be assessed carefully.
4. Conclusion
In the developing and developed world the induction of NAFLD, diabetes, neurological diseases and
Alzheimer’s disease is now connected to the handling and processing of food and may require cold preservation
procedures to prevent minimal bacterial and fungi contamination. The peripheral sink clearance Aβ pathway that
is critical to maintain neuron survival is inactivated by increased plasma/CSF contents of LPS and mycotoxin
with complete nullification of Starling’s equation for hydrostatic and oncotic pressure regulation in the brain
with relevance to the developing world. The brain and peripheral links to hepatic Aβ metabolism is now very
important not only to Alzheimer’s disease but to various neurological diseases, Type 3 diabetes, NAFLD. In the
developing world the gene-environment effects may not include the participation of the anti-aging gene Sirt 1
that is responsible for the maintenance of CSF circadian rhythm, neuron proliferation and peripheral Aβ
metabolism. LPS downregulates Sirt 1 and corrupts the Starling forces by interference with capillary membrane
fluidity and the regulation of albumin levels relevant to toxic Aβ and alpha-synuclein formation in the CSF and
brain. Peripheral Aβ metabolism is now relevant to diabetes and various neurological diseases and reversal of
neurological diseases/Alzheimer’s disease in the developed world now involves a healthy diet that promotes the
rapid Aβ transport from the brain to the CSF for rapid metabolism to the liver.
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